Emami Limited released its Investor Presentation in February 2026, highlighting resilient performance despite macro challenges. The presentation showcased a 5-year revenue CAGR of 8% and a PAT CAGR of 22%. Key strategies include diversifying from niche brands to new age/mainstream products, rejuvenating core brands, and disciplined capital deployment.
Resilient Financial Performance
Emami Limited demonstrated resilient performance despite higher inflation and subdued rural demand. The company achieved a 5-year CAGR (FY25) of 8% in Revenue, 8% in EBIDTA, and an impressive 22% in PAT. The adjusted PAT also showed a strong 9% CAGR. This was underpinned by strong cost discipline and agile execution.
FY25 Performance Highlights
The company reported a +7% increase in Domestic Net Sales (value) and +4% (volume). International Net Sales grew by +5% in constant currency and +4% in INR terms. Consolidated Revenues saw a +6% increase. Furthermore, the company experienced margin expansion, with Gross Margins increasing by +100 bps.
Brand Diversification and Rejuvenation
Emami is actively diversifying its brand portfolio from niche to new age/mainstream categories. Key brands like Navratna and Dermicool grew by 18%, while BoroPlus grew by 14%, and Zandu Healthcare increased by 12%. The company is also focused on brand rejuvenation, with relaunched Kesh King Gold featuring a new formulation, positioning and packaging. Smart and Handsome has been rebranded to target a broader grooming segment.
Strategic Investments and Acquisitions
Emami continues to make strategic investments in startups operating in high-growth segments. The company has a strong focus on market-leading, high-margin brands with strong consumer equity. The share of new age/mainstream portfolio has increased significantly, indicating a strategic shift in the company’s brand strategy.
Digital and E-commerce Growth
The company is focused on improving profitability in the D2C space. Digital spends constitute approximately 50% of overall media spends in 9MFY26, enabling sharper targeting and higher engagement. Zanducare, Emami’s digital healthcare ecosystem, has launched approximately 100 digital-first products and served over 2 lac patients through free online consultations.
International Business Expansion
Emami’s international business represents 17% of its overall revenue in FY25. The international business saw strong performance, with 39% of its revenue coming from SAARC & SEA, 44% from MENA, 11% from CIS, and 11% from Africa & Others.
Disciplined Capital Allocation
Emami has demonstrated disciplined capital deployment, with ₹2,024 cr in Cumulative Dividends, ₹663 cr in Cumulative Buybacks, and approximately ₹985 cr in Cumulative Acquisitions and Strategic Investments (FY21-9MFY26). The company maintains a strong net cash position of over ₹1,000 cr as of December 31, 2025.
Source: BSE
